In the 1980s, Baulieu and co-workers demonstrated that some steroids, such as pregnenolone (PREG), dehydroepiandrosterone and their sulfates, are present in higher concentrations in the brain than in blood and are synthesized de novo in the central nervous system. 1) Such steroids are now universally referred to as neurosteroids. They act as modulators of several neurotransmitter receptors (g-aminobutyric acid A , N-methyl-D-aspartate and s 1 receptors) either as stimulators or inhibitors 1, 2) and are involved in learning and memory performance.
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3) For these reasons, there is a considerable interest in determining the location and levels of different neurosteroids in the brain.
The levels of PREG sulfate (PREGS) have conventionally been evaluated by measuring its genin formed after solvolysis by GC-MS 4, 5) or radioimmunoassay (RIA). 6) However, these methods have some shortcomings, such as requirement of complicated pretreatment and solvolysis steps and a decline in the recovery rate of the steroid. To overcome these problems, we employed liquid chromatography (LC)-electrospray ionization (ESI)-MS-MS to determine PREGS in rat brains without deconjugation, 7) but contrary to our expectations, its levels were less than one tenth of those previously reported (more than 5 ng/g tissue). [4] [5] [6] One potential explanation for this discrepancy is that the LC-MS-MS method is more specific for brain samples than the GC-MS or RIA assay combined with solvolysis; the GC-MS may be detecting PREG derived from PREGS as well as that from other conjugated forms, such as sulfolipid conjugate, by solvolysis, and the RIA employs an antibody that reacts with other steroids having structures closely related to that of PREG. Although our LC-MS-MS method was specific and did not need a solvolysis procedure, it did not have sufficient sensitivity for the analysis of PREGS in the brain (limit of quantitation: ca. 160 pg/injection), and the obtained data using ca. 400 mg of tissue were not so reliable. 7) Based on the results, we developed an enzyme-linked immunosorbent assay (ELISA) for PREGS using an antibody raised against 11a-hemiglutaryloxy-PREGS-bovine serum albumin conjugate. 8) This ELISA is sensitive (limit of quantitation: 1 pg/well) and does not require solvolysis procedure. The present paper describes the application of the ELISA to the determination of PREGS in rat brains and some data concerning the source of the brain PREGS.
MATERIALS AND METHODS

Materials and Reagents
Standard PREGS, PREG and all other reagents were those used in the previous study. 8) Oasis HLB cartridges (60 mg: Waters Assoc., Milford, MA, U.S.A.) were successively washed with AcOEt (1 ml), EtOH (2 ml) and H 2 O (2 ml) prior to use.
Rats and Treatment Wistar strain rats (7 weeks old, male, 190-200 g) obtained from Japan S.L.C. (Hamamatsu, Japan) were used and euthanized by decapitation. Brain samples were collected from the rats assigned either to a control group (without injection, nϭ10), a group of animals receiving an intrapertioneal (i.p.) vehicle injection (5% EtOH/ saline, 5 ml/kg i.p., nϭ3) and a group receiving an injection of PREGS (dissolved in 5% EtOH/saline, 2 mg/5 ml/kg i.p., nϭ5). In the second and third groups, one hour following injection of vehicle or PREGS solution into the rat, the brain was collected. Blood from the control rats was collected from the cut end, left at 4°C for 2 h and then centrifuged at 1500 g (4°C, 10 min). The serum was separated and stored at Ϫ20°C.
Pretreatment Procedure The whole brain (1.6-1.8 g) was homogenized in 1% AcOH/MeOH (ca. 10 ml) using an ultrasonic homogenizer. The concentration of the homogenate was adjusted to 100 mg brain tissue/ml with 1% AcOH/MeOH, and 0.5 or 2 ml of homogenate (corresponding to 50 or 200 mg of brain tissue) was pipetted into tube. The sample was centrifuged at 1500 g (4°C, 10 min) and the supernatant was saved. The precipitate was further extracted with 1% AcOH/MeOH (0.5 ml) and centrifuged. The supernatant was combined and concentrated to about half volume under an N 2 gas stream. Hexane (1 ml) was added to the solution and vortex-mixed. The hexane layer was discarded, and the MeOH layer was evaporated to dryness following an additional washing with hexane (1 ml). The resulting residue was dissolved in 0.05 M NaH 2 PO 4 -Na 2 HPO 4 (pH 7.4, 0.5 ml) and applied to an Oasis HLB cartridge. After the cartridge was washed with H 2 O (2 ml) and AcOEt (1 ml), PREGS was eluted with EtOH (1.5 ml). The solvent was evaporated under an N 2 gas stream, and the residue was dissolved in EtOH (100 ml). Three 25 ml aliquots of the sample were submitted for ELISA. 8) In the case where the regional levels of PREGS were measured, the brain tissue (50-200 mg) was homogenized in 1% AcOH/MeOH (1 ml) and then treated in the same way as described above.
A serum sample (200 ml) was added to 1% AcOH/MeOH (1 ml) and vortex-mixed for 30 s. The mixture was centrifuged at 1500 g (4°C, 10 min) and the supernatant was saved. The precipitate was further extracted with 1% AcOH/MeOH (0.5 ml) and centrifuged. The supernatant was combined and treated in the same way as the brain sample.
Absolute Recovery Rate Standard PREGS in EtOH (25 ml) was added to the brain homogenate (0, 100 or 200 pg/200 mg brain) or the serum (0 or 200 pg/200 ml serum) of the control rat, and the resulting samples were pretreated and subjected to ELISA. The absolute recovery rateϭ(FϪF 0 )/Aϫ100, where A is PREGS added, F is PREGS in the spiked brain or serum, and F 0 is PREGS in the unspiked brain or serum.
Validation Studies Influence of sample volume and intra-and inter-assay variation were examined using the brain homogenate of the PREGS-injected rats. Interference of PREG in the assay was studied as follows. Standard PREG (2 or 5 ng) in EtOH (25 ml) was added to the brain homogenate of the PREGS-injected rats (brain: 200 mg), and the resulting samples were pretreated and subjected to ELISA. The assay values of the PREG-spiked samples were compared to those of the unspiked samples.
RESULTS AND DISCUSSION
Applicability of the ELISA to the Determination of PREGS in Rat Brains
The validation studies of the ELISA were carried out prior to the measurement of the brain PREGS levels. According to the brain levels of PREGS previously reported (more than 5 ng/g tissue), [4] [5] [6] the ELISA is able to determine them with less than 20 mg of tissue. However, anticipating that the concentration was lower, 7) 200 mg of tissue was used except for the study on the influence of sample volume. The whole brain was homogenized by the method of Liere et al., 4) by which steroids are reported to be quantitatively extracted from the brain tissue. The absolute recovery rates of PREGS during the washing and solid phase extraction steps were 60.2Ϯ5.3% and 61.4Ϯ9.4% [meanϮstandard deviation (S.D.), nϭ5 each] in the sample spiked with 0.5 ng and 1 ng/g tissue of PREGS, respectively; therefore, the average recovery rate (60.8%, nϭ10) was used for calculating the brain PREGS concentration in the following studies.
The antibody used in this ELISA showed a small cross-reactivity with PREG (4.4%), 8) and according to our data, PREG is present in higher concentration in the brain than its sulfate. 7, 9) To avoid the overestimation of the PREGS levels due to the contaminant of PREG, a purification procedure using the Oasis HLB cartridge was employed in the present assay, which was very useful in separating unconjugated steroids and sulfates. 8, 10) The interference of PREG on the assay was examined using the PREG-spiked samples (10 or 25 ng/g tissue spiked). The brain PREGS concentrations of the spiked and unspiked samples were similar (Table 1) , which indicates that the assay values by the ELISA are not influenced by PREG in the brain.
The ELISA afforded similar brain PREGS levels at sample volumes of 50 and 200 mg of brain tissue ( Table 1 ). The data indicate that the ELISA is applicable to the PREGS analysis not only in whole brain homogenate but also in small brain regions, such as the striatum (ca. 70 mg) and hippocampus (ca. 100 mg). When the maximum applicable volume (200 mg of brain) is used, 33 pg/g tissue of PREGS should be measurable, considering the recovery rate (60.8%) and quantitation limit (1 pg/well).
The intra-assay coefficient of variation (CV) values were less than 15.1% (nϭ4), and good inter-assay CV values (Ͻ9.2%, nϭ3) were also obtained as shown in Table 2 . Thus, the ELISA was proved to be sensitive and reliable for measuring PREGS in the brain by all the above validation data.
Measurement of Brain PREGS Levels in Rat The brain PREGS concentrations of most of the control rats (nϭ10) were less than 0.15 ng/g tissue (only one sample; 0.42 ng/g tissue) (Fig. 1) , which were much lower than those previously measured by GC-MS after solvolysis.
4,5) Although we did not sufficiently explain this discrepancy, there may be a possibility that the methods combined with solvolysis comeasured PREG derived from other conjugated forms in the brain as mentioned in the introductory section. Furthermore, PREGS levels of five regions (cerebral cortex, mid-brain, cerebellum, hippocampus and striatum) were also determined, but a region in which PREGS was localized was not found, and their levels (less than the limit of qantitation-0.17 ng/g tissue) were similar to that of the whole brain homogenate. Recently, a report that support our results was 710 Vol. 26, No. 5 published; Liu et al. 11) reported that PREGS could not be detected in rat brain using a capillary LC-ESI-MS-MS, which was sufficiently sensitive (detection limit: 0.3 ng/g tissue) and did not require deconjugation. This report also described that the brain level of a different sulfated steroid determined by the method was lower than that measured by GC-MS after solvolysis.
The brain PREGS levels were sufficiently increased compared to the controls after i.p. injection of PREGS (nϭ5, 0.37-1.29 ng/g tissue) (Fig. 1) . In the vehicle-injected rats, the brain PREGS levels were similar to those of the control rats. Wang et al. 12) reported that PREGS in blood can cross the blood-brain barrier without being hydrolyzed to the more lipophilic PREG and can be taken up by the brain. The serum PREGS concentrations of the control rats determined by the ELISA (nϭ5) were between 0.25 and 0.47 ng/ml [recovery rate; 70.1Ϯ2.3% (meanϮS.D., nϭ5)], which were significantly higher than the brain levels (Fig. 1) . To date, various steroids are dealt with as neuroactive steroids, though they are synthesized in the central or peripheral nervous system or are derived from peripheral sources, but with an action on neuronal tissue. Because there are sufficient data to prove that PREGS can act as modulators of neurotransmitter receptors, 1, 2) it is evident that the sulfate is a 'neuroactive steroid.' Although the occurrence of the enzymes mediating PREGS synthesis from cholesterol in the brain (cytochrome P450 cholesterol side-chain cleavage and sulfotransferase) has been demonstrated, 1) our data indicate that the amount of PREGS synthesized de novo in the brain is much smaller than that hitherto estimated, and most of PREGS in the brain may be transformed from peripheral sources.
In conclusion, PREGS in rat brains is much smaller than that previously reported [4] [5] [6] and the majority of it may be derived from peripheral sources. The biological significance of PREGS as an endogenous neurosteroid is open to reconsideration. 
